Scholars Central

Editor

Paul A. Lapchak

Department of Neurology Davis Research Building D-2091, Director of Translational Research Cedars-Sinai Medical Center, USA

About

As published by the journal they serve.

Dr. Paul A. Lapchak has received his PhD in Pharmacology in 1988 from McGill University (Montreal, Quebec). Currently, he is the Director of Translational Research at Cedars-Sinai Medical Center in Los Angeles, CA. Prior to joining Cedars-Sinai Medical Center, while at the University of California, Dr. Lapchak advanced 2 embolic stroke models to develop new stroke treatments. He is currently serving as an editorial member of Translational Stroke Research and is an active reviewer for STROKE, Experimental Neurology, Brain Research, amongst others. He has authored over 100 peer-reviewed research articles, over 40 review articles and is currently co-editing a new book entitled Translational Stroke Research: From target selection to clinical trials. He is a member of American Heart Association and the Society For Neuroscience. He has been honored as a Fellow of the American Heart Organization (FAHA) for his dedication to the translational development of novel methods to treat acute ischemic stroke and hemorrhagic stroke and has also received a Chemical Industry Award honor.

Journals they serve

The seats these journals name them in.

Articles we hold

Articles in the journals they serve whose byline carries this name.

This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels